The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Convergence 2020 Kicks Off: Plenary session speakers highlight racial differences in lupus & COVID-19-related findings

ACR Convergence 2020 Kicks Off: Plenary session speakers highlight racial differences in lupus & COVID-19-related findings

November 7, 2020 • By Ruth Jessen Hickman, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR Convergence graphicACR CONVERGENCE 2020—The ACR’s first fully virtual annual meeting kicked off on Thursday, Nov. 5. During the Opening Session, ACR President Ellen M. Gravallese, MD, talked about how the specialty’s response during the pandemic has provided great hope and will help rheumatology become an even more essential specialty.

You Might Also Like
  • Top Research in Lupus Presented at ACR Convergence 2020
  • ACR Convergence 2020: COVID-19 Hyper-Inflammation in Kids
  • COVID-19 Perspectives Shared in ACR Convergence Opening Session
Explore This Issue
December 2020
Also By This Author
  • How Immunosuppression May Affect COVID-19 Vaccine Response

At the first Plenary Session on Friday, Nov. 6, speakers highlighted findings relevant to the COVID-19 pandemic: the potential pathogenicity of antiphospholipid antibodies and the risks of poor outcomes in infected people with rheumatic diseases. Another key topic: Racial differences in lupus patients with respect to potential disease markers and outcomes in stroke and ischemic heart disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Antiphospholipid Antibodies in COVID-19
Accumulating evidence has raised concerns about the risks of arterial and venous thrombosis in patients with COVID-19. Yu (Ray) Zuo, MD, a clinical assistant professor in the Division of Rheumatology, University of Michigan, Ann Arbor, discussed the role prothrombotic antiphospholipid antibodies may be playing in COVID-19 pathophysiology.

As a part of acquired antiphospholipid syndrome, such antibodies promote thrombus formation. “Catastrophic antiphospholipid syndrome is the most severe type and is frequently fatal,” Dr. Zuo noted. “Clinically, it bears some similarities with severe COVID-19, such as cytokine storms and diffuse coagulopathy.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Previous small case reports and series suggested antiphospholipid antibodies might be present in COVID-19 patients and might be contributing to thrombosis. Viral infections generally are a well-known trigger for the transient appearance of these antibodies, but their overall pathogenicity remains poorly understood.

Dr. Zuo and colleagues obtained serum from 172 patients who had been hospitalized for COVID-19 and checked for eight different types of antiphospholipid antibodies. Fifty-two percent were positive for at least one.

“To our surprise, the most prevalent antiphospholipid antibody among COVID patients was not a well-studied one: [anti-phosphatidylserine/prothrombin] IgG,” Dr. Zuo related. This antibody is not currently part of standard antiphospholipid syndrome criteria, but it is thought to correlate with rates of thrombosis.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In other analyses, the team found higher levels of antiphospholipid antibodies in patients with more severe manifestations of COVID-19. Positivity for various antiphospholipid antibodies was associated with higher levels of neutrophil extracellular trap (NET) formation, as well as with a lower estimated glomerular filtration rate and more severe respiratory disease. High levels of NETs have also been demonstrated in hospitalized COVID-19 patients with severe respiratory impairment. Past work in antiphospholipid syndrome patients has demonstrated higher levels of circulating NETs, which may play a role in thrombosis.

Pages: 1 2 3 4 | Single Page

Filed Under: ACR Convergence, Conditions, Meeting Reports, SLE (Lupus), Systemic Inflammatory Syndromes Tagged With: ACR Convergence 2020, ACR Convergence 2020 - SLE, COVID-19, Global Rheumatology AllianceIssue: December 2020

You Might Also Like:
  • Top Research in Lupus Presented at ACR Convergence 2020
  • ACR Convergence 2020: COVID-19 Hyper-Inflammation in Kids
  • COVID-19 Perspectives Shared in ACR Convergence Opening Session
  • ACR Convergence 2020: Study Data for Lupus & Rheumatoid Arthritis

About Ruth Jessen Hickman, MD

Ruth Jessen Hickman, MD, was born and raised in eastern Kentucky, where she first cultivated her love of literature, writing and personal narratives. She attended Kenyon college, where she received a Bachelor of Arts in philosophy, summa cum laude. She worked with individuals with psychiatric conditions and later in a neuroscience lab at the University of Illinois, Chicago, before graduating from Indiana University Medical School in 2011. Instead of pursuing clinical medicine, Ruth opted to build on her strength of clearly explaining medical topics though a career as a freelance medical writer, writing both for lay people and for health professionals. She writes across the biomedical sciences, but holds strong interests in rheumatology, neurology, autoimmune diseases, genetics, and the intersection of broader social, cultural and emotional contexts with biomedical topics. Ruth now lives in Bloomington, Ind., with her husband, son and cat. She can be contacted via her website at ruthjessenhickman.com.

View more by this author»

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)